HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

B&K CORP-B

3.700

-0.150-3.90%

Volume:60.20K

Turnover:220.99K

Market Cap:435.33M

PE:-1.78

High:3.960

Open:3.960

Low:3.500

Close:3.850

52wk High:37.200

52wk Low:3.500

Shares:117.66M

HK Float Shares:83.02M

Volume Ratio:3.69

T/O Rate:0.07%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.080

ROE:-53.92%

ROA:-29.66%

PB:0.67

PE(LYR):-1.78

PS:713.54

Loading ...

Overview Company News Filings

B&K Corp. 2026 Interim: Wider RMB121.92 Million Loss as R&D Spend Jumps 58.8%; Core Burn & DFU Therapies Advance

Bulletin Express

B&K Corp Secures Shareholder Support for Full Share Circulation, Interim Dividend and New Share Award Scheme

Bulletin Express

B&K Corporation Publishes Full Articles of Association in Preparation for Hong Kong H-Share Listing

Bulletin Express

B&K Corp sets 4 Sept EGM to seek approval for full H-share circulation, new 10-year share award scheme and interim dividend plan

Bulletin Express

B&K Corporation Schedules 4 Sept 2026 EGM to Vote on Full-Circulation, Interim Dividend and Share Award Scheme

Bulletin Express

B&K Corp Announces Extraordinary General Meeting

B&K Corp Proposes Full Circulation of 21.68 Million Domestic Shares; Extraordinary Meeting Set for 4 September 2026

Bulletin Express

B&K unveils 10-year Share Award Scheme; first batch of 2.33 million shares earmarked for an employee and a consultant

Bulletin Express

B&K CORP-B (02396) Seeks Full Circulation of H Shares

B&K Corp Proposes Bylaw Changes to Streamline Unlisted-Share Conversion into Hong Kong-Traded H Shares

B\u0026K CORP-B (02396) Reports 40.65% Wider Net Loss of 122 Million Yuan in Interim Results

B&K CORP-B 1H26 Net Loss Expands 40.6% to RMB121.92 Million amid Heavier R&D Outlay

Bulletin Express

B&K Corp H1 FY26 Loss Widens 40.6% to RMB 121.92 Million

B&K Corp Schedules 14 August 2026 Board Meeting to Approve 1H26 Results and Consider Interim Dividend

Bulletin Express

B&K Corp Sets Board Meeting to Weigh Interim Results, Possible Dividend

B&K Reports Stable Share Capital and Full Public Float Compliance in July 2026 Update

Bulletin Express

B&K Announces Chinese Name Change to 青城新藥生物科技(青島)股份有限公司; Chinese Stock Short Name Shifts to「青城新藥－B」on 22 July 2026

Bulletin Express

B&K CORP-B Announces Formal Name Change to Qingcheng New Drug Biotechnology

B&K: Completes Full Enrollment for Phase II Trial of Diabetic Foot Ulcer Therapy Pro-101-2

Bulletin Express

B&K Completes Phase II Trial Enrollment for Pro-101-2 Diabetic Foot Ulcer Treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/02396/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02396","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02396\",,,,,undefined,":{"symbol":"02396","market":"HK","secType":"STK","nameCN":"B&K CORP-B","latestPrice":3.7,"timestamp":1789541074224,"preClose":3.85,"halted":0,"volume":60200,"delay":0,"changeRate":-0.03896103896103894,"floatShares":83022145,"shares":117657522,"eps":-2.08,"marketStatus":"Not Yet Opened","change":-0.15,"latestTime":"09-16 14:44:34","open":3.96,"high":3.96,"low":3.5,"amount":220994,"amplitude":0.119481,"askPrice":3.85,"askSize":1000,"bidPrice":3.7,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-2.39,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789608600000},"marketStatusCode":0,"adr":0,"listingDate":1766332800000,"exchange":"SEHK","adjPreClose":3.85,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"volumeRatio":3.6887255240998056,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02396\",,,,,undefined,":{"symbol":"02396","floatShares":83022145,"roa":"-29.66%","roe":"-53.92%","lyrEps":-2.08,"volumeRatio":3.6887255240998056,"shares":117657522,"dividePrice":0,"high":3.96,"amplitude":0.119481,"preClose":3.85,"low":3.5,"week52Low":3.5,"pbRate":"0.67","psRate":"713.54","week52High":37.2,"institutionHeld":0,"latestPrice":3.7,"eps":-2.08,"divideRate":0,"volume":60200,"delay":0,"ttmEps":-2.39,"open":3.96,"prevYearClose":16.17,"prevWeekClose":4.18,"prevMonthClose":4.88,"prevQuarterClose":4.08,"fiveDayClose":4.395,"twentyDayClose":4.95,"sixtyDayClose":4.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02396\",params:#limit:5,,,undefined,":[{"date":"2026-08-14","symbol":"02396","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786671000000,"name":null,"time":"","dateTimestamp":1786636800000,"actualEps":null},{"date":"2026-03-30","symbol":"02396","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02396\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02396\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02396\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02396","date":"2026-09-15","current":-1.548117,"percent":1,"low":-22.370893,"twenty":-5.306097,"median":-2.47843,"eighty":-1.89249,"high":-1.587826,"avg":-3.784334,"sd":2.709085,"marketCap":452981459},"quantilePoints":[{"date":"2025-12-19","current":-22.370893,"twenty":-22.370893,"median":-22.370893,"eighty":-22.370893,"marketCap":5247525481},{"date":"2025-12-24","current":-12.774079,"twenty":-17.071319,"median":-13.156175,"eighty":-12.763931,"marketCap":2586112333},{"date":"2026-01-02","current":-9.273817,"twenty":-13.232594,"median":-12.516848,"eighty":-9.766713,"marketCap":1884873502},{"date":"2026-01-09","current":-7.148857,"twenty":-12.763931,"median":-9.361922,"eighty":-7.100351,"marketCap":1456600122},{"date":"2026-01-16","current":-6.722795,"twenty":-12.56322,"median":-7.752698,"eighty":-6.987427,"marketCap":1374239856},{"date":"2026-01-23","current":-6.1704,"twenty":-11.520552,"median":-7.202103,"eighty":-6.484159,"marketCap":1260112060},{"date":"2026-01-30","current":-5.620424,"twenty":-9.969109,"median":-7.000858,"eighty":-6.122005,"marketCap":1153043715},{"date":"2026-02-06","current":-5.074187,"twenty":-9.32668,"median":-6.831002,"eighty":-5.802397,"marketCap":1043622220},{"date":"2026-02-13","current":-5.289789,"twenty":-8.733132,"median":-6.318622,"eighty":-5.490299,"marketCap":1094214954},{"date":"2026-02-20","current":-5.314508,"twenty":-8.192447,"median":-6.303522,"eighty":-5.373181,"marketCap":1097744680},{"date":"2026-02-27","current":-5.239953,"twenty":-7.651053,"median":-6.089741,"eighty":-5.311704,"marketCap":1094214954},{"date":"2026-03-06","current":-4.96445,"twenty":-7.41652,"median":-5.866722,"eighty":-5.258632,"marketCap":1028326742},{"date":"2026-03-13","current":-4.540249,"twenty":-7.236648,"median":-5.782264,"eighty":-5.14321,"marketCap":944789901},{"date":"2026-03-20","current":-4.296428,"twenty":-7.159506,"median":-5.556529,"eighty":-5.006513,"marketCap":890667441},{"date":"2026-03-27","current":-4.125305,"twenty":-7.084183,"median":-5.376979,"eighty":-4.752904,"marketCap":853017034},{"date":"2026-04-02","current":-4.190517,"twenty":-6.987427,"median":-5.341502,"eighty":-4.651676,"marketCap":870665662},{"date":"2026-04-10","current":-4.209019,"twenty":-6.916847,"median":-5.307499,"eighty":-4.524615,"marketCap":881254839},{"date":"2026-04-17","current":-4.207253,"twenty":-6.845738,"median":-5.289789,"eighty":-4.24209,"marketCap":881254839},{"date":"2026-04-24","current":-2.580199,"twenty":-6.809361,"median":-5.233134,"eighty":-4.158607,"marketCap":618514980},{"date":"2026-04-30","current":-2.370918,"twenty":-6.722795,"median":-5.166911,"eighty":-4.112803,"marketCap":568701693},{"date":"2026-05-08","current":-1.990933,"twenty":-6.325068,"median":-5.074187,"eighty":-4.070121,"marketCap":479037776},{"date":"2026-05-15","current":-1.944413,"twenty":-6.312176,"median":-4.99074,"eighty":-4.003624,"marketCap":469075119},{"date":"2026-05-22","current":-1.869532,"twenty":-6.294869,"median":-4.801286,"eighty":-2.572587,"marketCap":449980025},{"date":"2026-05-29","current":-2.406462,"twenty":-6.195294,"median":-4.744727,"eighty":-2.47593,"marketCap":581228158},{"date":"2026-06-05","current":-2.524582,"twenty":-6.105873,"median":-4.639702,"eighty":-2.50499,"marketCap":610642539},{"date":"2026-06-12","current":-2.336454,"twenty":-6.04436,"median":-4.520707,"eighty":-2.447556,"marketCap":564756105},{"date":"2026-06-18","current":-2.18581,"twenty":-5.937353,"median":-4.327355,"eighty":-2.373779,"marketCap":529458849},{"date":"2026-06-26","current":-2.039753,"twenty":-5.865351,"median":-4.218762,"eighty":-2.296626,"marketCap":491808441},{"date":"2026-07-03","current":-2.096742,"twenty":-5.856594,"median":-4.198885,"eighty":-2.202961,"marketCap":505927344},{"date":"2026-07-10","current":-1.78198,"twenty":-5.823918,"median":-4.125305,"eighty":-2.10196,"marketCap":429449955},{"date":"2026-07-17","current":-1.829174,"twenty":-5.777173,"median":-4.108105,"eighty":-2.059285,"marketCap":442392282},{"date":"2026-07-24","current":-1.896855,"twenty":-5.709892,"median":-4.095167,"eighty":-2.009543,"marketCap":458864335},{"date":"2026-07-31","current":-1.762187,"twenty":-5.594866,"median":-4.054956,"eighty":-1.985679,"marketCap":427096804},{"date":"2026-08-07","current":-1.865363,"twenty":-5.474817,"median":-4.009947,"eighty":-1.920991,"marketCap":452981459},{"date":"2026-08-14","current":-1.8872,"twenty":-5.398235,"median":-2.580199,"eighty":-1.89994,"marketCap":458864335},{"date":"2026-08-21","current":-2.708337,"twenty":-5.373181,"median":-2.575598,"eighty":-1.89994,"marketCap":771245056},{"date":"2026-08-28","current":-2.015818,"twenty":-5.354692,"median":-2.542127,"eighty":-1.905189,"marketCap":574168707},{"date":"2026-09-04","current":-1.899394,"twenty":-5.336103,"median":-2.526416,"eighty":-1.8992,"marketCap":541224601},{"date":"2026-09-11","current":-1.723645,"twenty":-5.311704,"median":-2.51163,"eighty":-1.896058,"marketCap":491808441},{"date":"2026-09-15","current":-1.587826,"twenty":-5.306097,"median":-2.47843,"eighty":-1.89249,"marketCap":452981459}],"updateTime":1789593892908},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02396\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1135794141","title":"B&K Corp. 2026 Interim: Wider RMB121.92 Million Loss as R&D Spend Jumps 58.8%; Core Burn & DFU Therapies Advance","url":"https://stock-news.laohu8.com/highlight/detail?id=1135794141","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135794141?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:05","pubTimestamp":1789391112,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited (B&K Corp.) reported a RMB121.92 million (USD16.9 million) first-half 2026 net loss, widening 40.6% year on year from RMB86.68 million, as aggressive investment in drug...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"B&K Corp. 2026 Interim: Wider RMB121.92 Million Loss as R&D Spend Jumps 58.8%; Core Burn & DFU Therapies Advance","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187076191","title":"B&K Corp Secures Shareholder Support for Full Share Circulation, Interim Dividend and New Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1187076191","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187076191?lang=en_us&edition=fundamental","pubTime":"2026-09-04 22:02","pubTimestamp":1788530564,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited (B&K Corp) reported unanimous shareholder approval for all agenda items at its second extraordinary general meeting held on 4 September 2026 in Qingdao. A total of 91.95...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173525278","title":"B&K Corporation Publishes Full Articles of Association in Preparation for Hong Kong H-Share Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1173525278","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173525278?lang=en_us&edition=fundamental","pubTime":"2026-09-04 22:01","pubTimestamp":1788530512,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited (B&K Corporation) has released its Articles of Association in advance of its planned H-share listing on the Main Board of The Stock Exchange of Hong Kong, laying out the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195130010","title":"B&K Corp sets 4 Sept EGM to seek approval for full H-share circulation, new 10-year share award scheme and interim dividend plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1195130010","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195130010?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:07","pubTimestamp":1787234852,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited will convene an extraordinary general meeting (EGM) in Beijing on 4 September 2026 to vote on seven major proposals aimed at reshaping its capital base and incentive...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159462823","title":"B&K Corporation Schedules 4 Sept 2026 EGM to Vote on Full-Circulation, Interim Dividend and Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159462823","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159462823?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:07","pubTimestamp":1787234828,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited (B&K CORP-B, stock code: 02396) has convened its 2026 second extraordinary general meeting (EGM) for 10:00 a.m. on Friday, 4 September 2026 at the Metropark Hotel Yingkun...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660803212","title":"B&K Corp Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2660803212","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660803212?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:51","pubTimestamp":1787233868,"startTime":"0","endTime":"0","summary":"B&K Corp announces extraordinary general meetingB&K Corporation will hold an extraordinary general meeting in Beijing on Sept. 4, 2026.Shareholders will vote on a plan to convert 21,681,762 domestic u","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL5BGnRg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131384574","title":"B&K Corp Proposes Full Circulation of 21.68 Million Domestic Shares; Extraordinary Meeting Set for 4 September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1131384574","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131384574?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:28","pubTimestamp":1786714103,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited announced plans to convert 21.68 million domestic shares—representing 18.43% of its total share capital—into H-shares for listing and trading on the Hong Kong Stock Exchange....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119535624","title":"B&K unveils 10-year Share Award Scheme; first batch of 2.33 million shares earmarked for an employee and a consultant","url":"https://stock-news.laohu8.com/highlight/detail?id=1119535624","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119535624?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:26","pubTimestamp":1786714006,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited plans to launch a new H-share award scheme and will seek shareholder approval at an extraordinary general meeting scheduled for 4 September 2026. Key features of the proposed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199474422","title":"B&K CORP-B (02396) Seeks Full Circulation of H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1199474422","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199474422?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:50","pubTimestamp":1786711826,"startTime":"0","endTime":"0","summary":"B&K CORP-B (02396) announced that, in accordance with the guidelines, the board has reviewed and approved the conversion of domestic shares held by participating shareholders into H shares, as well...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659301141","title":"B&K Corp Proposes Bylaw Changes to Streamline Unlisted-Share Conversion into Hong Kong-Traded H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2659301141","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659301141?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:39","pubTimestamp":1786711183,"startTime":"0","endTime":"0","summary":"B&K Corp proposes bylaw changes to streamline unlisted-share conversion into Hong Kong-traded H sharesB&K proposed articles-of-association changes tied to its planned conversion of domestic unlisted s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDLgZWTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146715237","title":"B\\u0026K CORP-B (02396) Reports 40.65% Wider Net Loss of 122 Million Yuan in Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1146715237","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146715237?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:20","pubTimestamp":1786706413,"startTime":"0","endTime":"0","summary":"B\\u0026K CORP-B (02396) has released its interim results for the six months ended 30 June 2026, showing a net loss attributable to owners of the parent of 122 million yuan, a 40.65% increase...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129911574","title":"B&K CORP-B 1H26 Net Loss Expands 40.6% to RMB121.92 Million amid Heavier R&D Outlay","url":"https://stock-news.laohu8.com/highlight/detail?id=1129911574","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129911574?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:08","pubTimestamp":1786705692,"startTime":"0","endTime":"0","summary":"Hong Kong–listed biopharma developer B&K CORP-B reported an unaudited net loss of RMB121.92 million for the six months ended 30 June 2026, widening 40.6% year-on-year, as the company accelerated...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"B&K CORP-B 1H26 Net Loss Expands 40.6% to RMB121.92 Million amid Heavier R&D Outlay","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659143755","title":"B&K Corp H1 FY26 Loss Widens 40.6% to RMB 121.92 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659143755","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659143755?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:03","pubTimestamp":1786705413,"startTime":"0","endTime":"0","summary":"B&K Corp H1 FY26 loss widens 40.6% to RMB 121.92 millionB&K posted a net loss of RMB 121.92 million for the six months ended June 30, widening 40.6% year over year.Loss per share attributable to owner","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL3ngHsf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125385556","title":"B&K Corp Schedules 14 August 2026 Board Meeting to Approve 1H26 Results and Consider Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1125385556","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125385556?lang=en_us&edition=fundamental","pubTime":"2026-08-04 17:45","pubTimestamp":1785836730,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited announced that its board of directors will meet on 14 August 2026 to review and approve the interim financial results for the six months ended 30 June 2026. The agenda also...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656531566","title":"B&K Corp Sets Board Meeting to Weigh Interim Results, Possible Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2656531566","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656531566?lang=en_us&edition=fundamental","pubTime":"2026-08-04 17:41","pubTimestamp":1785836500,"startTime":"0","endTime":"0","summary":"B&K Corp sets board meeting to weigh interim results, possible dividendB&K Corporation will hold a board meeting on Aug. 14, 2026 to review interim results for the six months ended June 30, 2026.The b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDLbX3nGR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131929217","title":"B&K Reports Stable Share Capital and Full Public Float Compliance in July 2026 Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1131929217","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131929217?lang=en_us&edition=fundamental","pubTime":"2026-08-03 22:26","pubTimestamp":1785767194,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited (B&K) has submitted its Monthly Return to Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026, confirming that its share capital structure and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192798385","title":"B&K Announces Chinese Name Change to 青城新藥生物科技(青島)股份有限公司; Chinese Stock Short Name Shifts to「青城新藥－B」on 22 July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1192798385","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192798385?lang=en_us&edition=fundamental","pubTime":"2026-07-17 17:02","pubTimestamp":1784278943,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited has formally completed the change of its registered Chinese name from「華芢生物科技(青島)股份有限公司」to「青城新藥生物科技(青島)股份有限公司」, effective 13 July 2026. The English name “B&K Corporation...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110015801","title":"B&K CORP-B Announces Formal Name Change to Qingcheng New Drug Biotechnology","url":"https://stock-news.laohu8.com/highlight/detail?id=1110015801","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110015801?lang=en_us&edition=fundamental","pubTime":"2026-07-17 16:45","pubTimestamp":1784277942,"startTime":"0","endTime":"0","summary":"An announcement has been issued by B&K CORP-B (ASX: 02396) regarding a formal alteration to its corporate identity.The company's registered Chinese name has been officially changed from \"Huaren...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYNB","BK1161","BK4588","XBI","MEDX","159837","BK4581","HBImain","02396","BK4585","AGNG","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194702144","title":"B&K: Completes Full Enrollment for Phase II Trial of Diabetic Foot Ulcer Therapy Pro-101-2","url":"https://stock-news.laohu8.com/highlight/detail?id=1194702144","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194702144?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:20","pubTimestamp":1783945239,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited (B&K) disclosed that patient enrollment for the Phase II clinical trial of its recombinant human platelet-derived growth factor BB (rhPDGF-BB) gel, Pro-101-2, has been...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651119055","title":"B&K Completes Phase II Trial Enrollment for Pro-101-2 Diabetic Foot Ulcer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2651119055","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651119055?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:14","pubTimestamp":1783944868,"startTime":"0","endTime":"0","summary":"B&K completes Phase II trial enrollment for Pro-101-2 diabetic foot ulcer treatmentB&K reported full patient enrollment in its Phase II trial of Pro-101-2 for diabetic foot ulcers.No results were pres","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL2d1jPX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02396"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}]}}